Market-Moving News for September 18th
Portfolio Pulse from ryanfaloona@benzinga.com
SeqLL shares are trading higher after the company announced the date of its cash and stock dividend. RedHill announced FDA sNDA approval for Talicia®. Avinger initiates full commercial launch of Tigereye ST Image-Guided CTO Crossing Device.
September 18, 2023 | 12:48 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Avinger initiates full commercial launch of Tigereye ST Image-Guided CTO Crossing Device.
Product launches can lead to a rise in share price as they represent potential new revenue streams for the company.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
RedHill announced FDA sNDA approval for Talicia®.
FDA approval is a significant milestone for pharmaceutical companies, often leading to a rise in share price as it allows the company to market and sell the approved drug.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
SeqLL announced the date of its cash and stock dividend, leading to a rise in its share price.
Dividend announcements often lead to a rise in share price as they indicate a company's profitability and ability to return value to shareholders.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100